What did @josiejosiejosiejosi actually say?
The creator described taking an unspecified peptide after commenters recommended it for PMDD, specifically during the luteal phase. She expected results within an hour, reporting back the next day that it "did not meaningfully impact" her symptoms. She also asked a legitimate, if casual, question: if your period is late, are you still in your luteal phase?
To be clear about what peptide she was referring to: she never names it on screen. Based on the comment section context and the category tag, the recommendation appears to be Semax or Selank, both of which get floated in peptide communities for mood and anxiety. She's not claiming a cure. She's doing something more relatable, and arguably more honest: she tried it, it didn't work, and she said so. That candor is worth noting.
Does the science back this up?
Short answer: there is essentially no clinical evidence that any currently popular peptide meaningfully treats PMDD in humans. The condition is driven by abnormal sensitivity to normal hormonal fluctuations, particularly progesterone metabolites acting on GABA-A receptors, and the only treatments with solid evidence are SSRIs and hormonal suppression (Hantsoo & Eptein, 2015, Current Psychiatry Reports).
Selank has shown anxiolytic effects in rodent models and some small Russian clinical trials, primarily for generalized anxiety disorder, not PMDD specifically (Semenova et al., 2010, Bulletin of Experimental Biology and Medicine). The proposed mechanism, modulating GABA and serotonin pathways, is at least plausible on paper. But plausible mechanism does not equal clinical efficacy. No peer-reviewed trial has tested any peptide against PMDD as a primary endpoint. The creator's own n-of-1 result, no noticeable effect, is consistent with what the evidence would predict.
What did they get wrong (or right)?
She got the self-experiment outcome right, even if the premise was shaky. Her honest next-day update, that it did nothing, is more scientifically useful than most peptide content on this platform.
Her cycle phase question, however, deserves a real answer because she was genuinely confused. If a period is late, yes, you remain in the luteal phase until menstruation begins. The luteal phase does not revert to follicular on a timer. It ends when progesterone drops and bleeding starts. A delayed period simply means a prolonged luteal phase, which can itself worsen PMDD symptoms due to extended progesterone exposure (Yonkers et al., 2008, The Lancet). This is actually relevant to why she might have felt worse, not better, during this particular cycle.
What she got wrong is the framing that a peptide taken five minutes prior could plausibly shift a hormonally driven mood state within an hour. That's not how PMDD works, and it's not how any of these peptides are proposed to work even in optimistic models.
What should you actually know?
PMDD affects roughly 3 to 8 percent of people who menstruate, and it is a serious, diagnosable condition listed in the DSM-5. It is not, as the creator jokes, "anytime you experience a negative emotion." That framing, while self-deprecating and funny, accidentally minimizes a condition that causes significant functional impairment and carries elevated suicide risk during the luteal phase (Pilver et al., 2011, Journal of Affective Disorders).
If you are cycling through peptide recommendations from comment sections hoping to find something that works within the hour, that is a sign the underlying condition deserves actual clinical attention. First-line treatments include luteal-phase SSRIs, specifically fluoxetine and sertraline, which have Level A evidence. GnRH agonists exist for severe cases. A telehealth provider who actually evaluates your cycle history is a better starting point than TikTok comment sections, however well-meaning.
On the peptide side: if Selank or Semax were the recommendations here, they are not FDA-approved for any indication, carry limited human safety data outside small studies, and are typically administered via nasal spray or injection, not oral routes. Sourcing and dosing from unregulated suppliers adds meaningful risk that comment sections do not discuss.
Our bottom line
The creator deserves credit for reporting a null result honestly. That is rare in this space. But the underlying recommendation, that a peptide can acutely resolve PMDD symptoms, has no clinical evidence supporting it. The cycle phase biology she asked about is real and worth understanding. And anyone managing PMDD should know that actual, evidence-based treatment options exist and work significantly better than this.